上海医药(02607.HK)拟3月30日举行董事会会议审批年度业绩

Core Viewpoint - Shanghai Pharmaceuticals (02607.HK) will hold a board meeting on March 30, 2026, to approve the annual performance for the year ending December 31, 2025, and consider the distribution of a final dividend, if any [1] Group 1 - The board meeting is scheduled for March 30, 2026 [1] - The meeting will focus on approving the annual results for the fiscal year ending December 31, 2025 [1] - The board will also consider the potential distribution of a final dividend [1]